TOREMIFENE

SynDRA canonical compound SYN0016431 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CYP3A5 \| ESR1
Mechanism of action	estrogen receptor antagonist \| selective estrogen receptor modulator (SERM)
Indication	breast cancer
Disease area	oncology

All known targets

FC1157a
FC 1157a
fareston
chlortamoxifen
toremifene citrate
Toremifeno
Acapodene
Chlortamoxifen
Farestone
Toremiphene
GTX-006
J33.157K
Estrimex
Toremifenum
Toremifene Base
Toremifeno [Spanish]
Toremifenum [Latin]
GTx-006
Acapodene (TN)
FC-1157a
Fareston (TN)
Toremifene (INN)
Toremifene [INN:BAN]
Z-Toremifene
GTX-006 (Acapodene)
Toremifene Citrate (1:1)
{2-[4-(4-Chloro-1,2-diphenyl-but-1-enyl)-phenoxy]-ethyl}-dimethyl-amine
(Z)-2-(4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
2-(p-[(Z)-4-chloro-1,2-diphenyl-1-butenyl]-phenoxy)-N,N-dimethyl-ethylamine citrate(1:1)
2-(para-((Z)-4-Chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethylethylamine (IUPAC)
2-({4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenyl}oxy)-N,N-dimethylethanamine
2-[4-[(Z)-4-chloro-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
2-{4-[(1Z)-4-chloro-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
(E)-Toremifene
7NFE54O27T
CHEBI:9635
89778-26-7 (free base)
Ethanamine, 2-(4-((1Z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-